Notably, an antisense lncRNA, EPB41L4A-AS2 (NONHSAG041250.2), which is reported to inhibit tumor proliferation and is associated with favorable prognoses in breast cancer24, was identified as a hub gene in this module. The gene discussed is EPB41L4A; the disease is neoplasm.